Cellmid 2018 Annual Report
NOTES TO THE
Contingent liabilities and contingent assets
The parent entity has given bank guarantees as at 30 June 2018 of $129,560 (30 June 2017: $65,829) relating to the lease of
commercial ofﬁce space.
Guarantees entered into by the parent entity in relation to the debts of its subsidiaries
On 30 June 2016, Cellmid Limited entered into a deed of cross guarantee to support the liabilities and obligations of four of its
wholly-owned subsidiaries, Advangen Limited, Advangen International Pty Ltd, Kinera Limited and Lyramid Limited.
By entering into the deed, the wholly-owned entities have been relieved from the requirement to prepare a ﬁnancial report and
directors’ report under ASIC Corporations (Wholly-owned Companies) Instrument 2016/785 issued by the Australian Securities
and Investments Commission.
Apart from the items noted above the parent entity had no contingent liabilities or contingent assets at 30 June 2018.
The parent entity had no capital commitments at 30 June 2018 (Nil at 30 June 2017).
3. REVENUE AND OTHER INCOME
Revenue is recognised when it is probable that the economic beneﬁt will ﬂow to the Group and the revenue can be reliably
measured. Revenue is measured at the fair value of the consideration received or receivable and after taking into account any
trade discounts and volume rebates allowed.
Revenue from the sale of products is recognised at the point of delivery as this corresponds to the transfer of signiﬁcant risks
and rewards of ownership of the products and the cessation of all involvement in those products. When goods are held on
consignment by a third party, revenue is recognised when the goods are on sold by the third party.
Interest revenue is recognised as interest accrues using the effective interest rate method.
Royalties are recognised when it is probable that the economic beneﬁts associated with the transaction will ﬂow to the Group.
Government grants includes the research and development tax incentive. This represents a refundable tax offset that is
available on eligible research and development expenditure incurred by the Group. Government Grants are recognised in
proﬁt or loss when the grant is received.